HEADER IMMUNE SYSTYEM 09-APR-06 2CJV OBSLTE 03-APR-07 2CJV 2UUD TITLE CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- TITLE 2 OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH PHOXGABA COMPND MOL_ID: 1; COMPND 2 MOLECULE: NQ10-1.12 ANTI-PHOX ANTIBODY; COMPND 3 CHAIN: H; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: NQ10-1.12 ANTI-PHOX ANTIBODY; COMPND 6 CHAIN: J; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 3; COMPND 9 MOLECULE: NQ10-1.12 ANTI-PHOX ANTIBODY; COMPND 10 CHAIN: K, L; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 4; COMPND 13 MOLECULE: NQ10-1.12 ANTI-PHOX ANTIBODY; COMPND 14 CHAIN: S, T; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 STRAIN: BALB/C; SOURCE 5 CELL: HYBRIDOMA; SOURCE 6 OTHER_DETAILS: NQ10/1.12 ANTI-2-PHENYL-5-OXAZOLONE SOURCE 7 HYBRIDOMA; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 10 ORGANISM_COMMON: MOUSE; SOURCE 11 STRAIN: BALB/C; SOURCE 12 CELL: HYBRIDOMA; SOURCE 13 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 14 EXPRESSION_SYSTEM_STRAIN: GS115; SOURCE 15 EXPRESSION_SYSTEM_PLASMID: PPIC9KE; SOURCE 16 OTHER_DETAILS: NQ10/1.12 ANTI-2-PHENYL-5-OXAZOLONE SOURCE 17 HYBRIDOMA; SOURCE 18 MOL_ID: 3; SOURCE 19 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 20 ORGANISM_COMMON: MOUSE; SOURCE 21 STRAIN: BALB/C; SOURCE 22 CELL: HYBRIDOMA; SOURCE 23 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 24 EXPRESSION_SYSTEM_STRAIN: GS115; SOURCE 25 EXPRESSION_SYSTEM_PLASMID: PPIC9KE; SOURCE 26 OTHER_DETAILS: NQ10/1.12 ANTI-2-PHENYL-5-OXAZOLONE SOURCE 27 HYBRIDOMA; SOURCE 28 MOL_ID: 4; SOURCE 29 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 30 ORGANISM_COMMON: MOUSE; SOURCE 31 STRAIN: BALB/C; SOURCE 32 CELL: HYBRIDOMA; SOURCE 33 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 34 EXPRESSION_SYSTEM_STRAIN: GS115; SOURCE 35 EXPRESSION_SYSTEM_PLASMID: PPIC9KE; SOURCE 36 OTHER_DETAILS: NQ10/1.12 ANTI-2-PHENYL-5-OXAZOLONE SOURCE 37 HYBRIDOMA KEYWDS SCFV, ANTIBODY, IMMUNOGLOBULIN, 2-PHENYL-5-OXAZOLONE, KEYWDS 2 IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTYEM EXPDTA X-RAY DIFFRACTION AUTHOR C.SCOTTI,E.GHERARDI REVDAT 2 28-JUN-06 2CJV 1 JRNL REVDAT 1 20-JUN-06 2CJV 0 JRNL AUTH C.SCOTTI,E.GHERARDI JRNL TITL STRUCTURAL BASIS OF AFFINITY MATURATION OF THE JRNL TITL 2 TEPC15/VKAPPA45.1 ANTI-2-PHENYL-5-OXAZOLONE JRNL TITL 3 ANTIBODIES. JRNL REF J.MOL.BIOL. V. 359 1161 2006 JRNL REFN ASTM JMOBAK UK ISSN 0022-2836 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MLF REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 65.64 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 10354 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.328 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 499 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.015 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.03 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3310 REMARK 3 BIN FREE R VALUE : 0.4140 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.12 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.049 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3721 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 28 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 22.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM SIGMAA (A) : 0.48 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.53 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.65 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.64 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 26.63 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.93 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.420 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.450 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.830 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.920 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 37.50 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : NULL REMARK 3 TOPOLOGY FILE 1 : ION.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2CJV COMPLIES WITH FORMAT V. 3.0, 1-DEC-2006 REMARK 4 REMARK 4 THIS FILE IS A TEST VERSION. REMARK 4 REMARK 4 THIS IS THE REMEDIATED VERSION OF THIS PDB ENTRY. REMARK 4 REMEDIATED DATA FILE REVISION 3.101 (2007-05-01) REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY EBI ON 10-APR-2006. REMARK 100 THE EBI ID CODE IS EBI-27668. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-FEB-2002 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.60 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11988 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 65.640 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 3.900 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FLR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.47 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M TRIS-HCL, PH 7.6, 0.2 M REMARK 280 AMMONIUM SULPHATE, 30% PEG 4K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 1/2+X,1/2+Y,Z REMARK 290 4555 1/2-X,1/2+Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 70.47000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.83000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 70.47000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 37.83000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 295 REMARK 295 NON-CRYSTALLOGRAPHIC SYMMETRY REMARK 295 THE TRANSFORMATIONS PRESENTED ON THE MTRIX RECORDS BELOW REMARK 295 DESCRIBE NON-CRYSTALLOGRAPHIC RELATIONSHIPS AMONG ATOMS REMARK 295 IN THIS ENTRY. APPLYING THE APPROPRIATE MTRIX REMARK 295 TRANSFORMATION TO THE RESIDUES LISTED FIRST WILL YIELD REMARK 295 APPROXIMATE COORDINATES FOR THE RESIDUES LISTED SECOND. REMARK 295 CHAIN IDENTIFIERS GIVEN AS "?" REFER TO CHAINS FOR WHICH REMARK 295 ATOMS ARE NOT FOUND IN THIS ENTRY. REMARK 295 REMARK 295 APPLIED TO TRANSFORMED TO REMARK 295 TRANSFORM CHAIN RESIDUES CHAIN RESIDUES RMSD REMARK 295 M 1 J 1 .. 121 H 1 .. 121 0.550 REMARK 295 M 2 K 1 .. 113 L 1 .. 113 0.475 REMARK 295 M 3 T 1 .. 18 S 1 .. 18 3.439 REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 6 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, L, S, O, P, Q REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMOLECULE: 2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: J, K, T REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY S 6 REMARK 465 GLY S 7 REMARK 465 GLY S 8 REMARK 465 SER S 9 REMARK 465 GLY S 10 REMARK 465 GLY S 11 REMARK 465 GLY S 12 REMARK 465 GLY S 13 REMARK 465 SER S 14 REMARK 465 SER T 4 REMARK 465 GLY T 5 REMARK 465 GLY T 6 REMARK 465 GLY T 7 REMARK 465 GLY T 8 REMARK 465 SER T 9 REMARK 465 GLY T 10 REMARK 465 GLY T 11 REMARK 465 GLY T 12 REMARK 465 GLY T 13 REMARK 465 SER T 14 REMARK 465 GLY T 15 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 THR T 2 OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 C ALA H 113 N SER S 1 1.33 REMARK 500 C ALA J 113 N SER T 1 1.33 REMARK 500 N GLN K 1 C ALA T 18 1.33 REMARK 500 N GLN L 1 C ALA S 18 1.33 REMARK 500 CZ ARG K 54 OAL PHX H 1114 1.73 REMARK 500 O HOH H 1007 O HOH P 4 1.93 REMARK 500 CZ ARG L 54 OAP PHX J 1114 2.12 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH O 4 O HOH O 4 2655 0.97 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),F6.3) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 SER T 3 CB SER T 3 OG 1.504 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES: ENGH AND HUBER, 1991 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY J 95 N - CA - C ANGL. DEV. = 12.9 DEGREES REMARK 500 VAL J 111 N - CA - C ANGL. DEV. =-11.7 DEGREES REMARK 500 GLN K 1 N - CA - C ANGL. DEV. =-14.1 DEGREES REMARK 500 SER S 1 N - CA - C ANGL. DEV. =-17.2 DEGREES REMARK 500 SER S 3 N - CA - C ANGL. DEV. =-14.1 DEGREES REMARK 500 SER T 3 CA - CB - OG ANGL. DEV. =-56.2 DEGREES REMARK 500 ALA T 18 N - CA - C ANGL. DEV. = 10.9 DEGREES REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS H 43 139.64 11.67 REMARK 500 ASP H 96 129.10 119.09 REMARK 500 TYR H 98 -56.44 69.45 REMARK 500 TRP H 100A -65.25 75.08 REMARK 500 ALA J 44 148.02 105.94 REMARK 500 TRP J 100A -58.12 131.45 REMARK 500 VAL K 51 -38.10 65.90 REMARK 500 VAL L 51 -54.91 56.07 REMARK 500 SER S 3 135.11 121.83 REMARK 500 THR T 2 134.37 63.70 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 SITE_DESCRIPTION: PHX BINDING SITE FOR CHAIN H REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 SITE_DESCRIPTION: PHX BINDING SITE FOR CHAIN J REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2CJU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 REMARK 900 ANTI-2-PHENYL-5-OXAZOLONE NQ16-113.8 REMARK 900 SCFV IN COMPLEX WITH PHOXGABA DBREF 2CJV H 1 113 PDB 2CJV 2CJV 1 113 DBREF 2CJV J 1 113 PDB 2CJV 2CJV 1 113 DBREF 2CJV K 1 107 PDB 2CJV 2CJV 1 107 DBREF 2CJV L 1 107 PDB 2CJV 2CJV 1 107 DBREF 2CJV S 1 18 PDB 2CJV 2CJV 1 18 DBREF 2CJV T 1 18 PDB 2CJV 2CJV 1 18 SEQRES 1 H 121 GLU VAL LYS LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 H 121 PRO GLY GLY SER LEU ARG LEU SER CYS ALA THR SER GLY SEQRES 3 H 121 PHE SER PHE THR ASP TYR TYR MET ALA TRP VAL ARG GLN SEQRES 4 H 121 PRO PRO GLY LYS ALA LEU GLU TRP LEU ALA PHE ILE ARG SEQRES 5 H 121 ASN LYS ALA ASN GLY TYR THR THR ASP TYR SER ALA SER SEQRES 6 H 121 VAL LYS GLY ARG PHE THR ILE SER ARG ASP ASN SER GLN SEQRES 7 H 121 SER ILE LEU TYR LEU GLN MET ASN THR LEU ARG ALA GLU SEQRES 8 H 121 ASP SER ALA THR TYR TYR CYS ALA ARG GLY ASP TYR TYR SEQRES 9 H 121 GLY ALA TRP PHE ALA TYR TRP GLY GLN GLY THR LEU VAL SEQRES 10 H 121 THR VAL SER ALA SEQRES 1 J 121 GLU VAL LYS LEU VAL GLU SER GLY GLY GLY LEU VAL GLN SEQRES 2 J 121 PRO GLY GLY SER LEU ARG LEU SER CYS ALA THR SER GLY SEQRES 3 J 121 PHE SER PHE THR ASP TYR TYR MET ALA TRP VAL ARG GLN SEQRES 4 J 121 PRO PRO GLY LYS ALA LEU GLU TRP LEU ALA PHE ILE ARG SEQRES 5 J 121 ASN LYS ALA ASN GLY TYR THR THR ASP TYR SER ALA SER SEQRES 6 J 121 VAL LYS GLY ARG PHE THR ILE SER ARG ASP ASN SER GLN SEQRES 7 J 121 SER ILE LEU TYR LEU GLN MET ASN THR LEU ARG ALA GLU SEQRES 8 J 121 ASP SER ALA THR TYR TYR CYS ALA ARG GLY SER TYR TYR SEQRES 9 J 121 GLY ALA TRP PHE ALA TYR TRP GLY GLN GLY THR LEU VAL SEQRES 10 J 121 THR VAL SER ALA SEQRES 1 K 113 GLN VAL LEU MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 K 113 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 K 113 GLN SER ILE VAL HIS SER ASN GLY ASN THR TYR LEU GLU SEQRES 4 K 113 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 K 113 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 K 113 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 K 113 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 K 113 TYR CYS PHE GLN GLY SER HIS VAL PRO TYR THR PHE GLY SEQRES 9 K 113 GLY GLY THR LYS LEU GLU ILE LYS ARG SEQRES 1 L 113 GLN VAL LEU MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 L 113 SER LEU GLY ASP GLN ALA SER ILE SER CYS ARG SER SER SEQRES 3 L 113 GLN SER ILE VAL HIS SER ASN GLY ASN THR TYR LEU GLU SEQRES 4 L 113 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO LYS LEU LEU SEQRES 5 L 113 ILE TYR LYS VAL SER ASN ARG PHE SER GLY VAL PRO ASP SEQRES 6 L 113 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 113 LYS ILE SER ARG VAL GLU ALA GLU ASP LEU GLY VAL TYR SEQRES 8 L 113 TYR CYS PHE GLN GLY SER HIS VAL PRO TYR THR PHE GLY SEQRES 9 L 113 GLY GLY THR LYS LEU GLU ILE LYS ARG SEQRES 1 S 18 SER THR SER SER GLY GLY GLY GLY SER GLY GLY GLY GLY SEQRES 2 S 18 SER GLY GLY SER ALA SEQRES 1 T 18 SER THR SER SER GLY GLY GLY GLY SER GLY GLY GLY GLY SEQRES 2 T 18 SER GLY GLY SER ALA HET PHX H1114 20 HET PHX J1114 20 HETNAM PHX 4-{[(Z)-(5-OXO-2-PHENYL-1,3-OXAZOL-4(5H)-YLIDENE) HETNAM 2 PHX METHYL]AMINO}BUTANOIC ACID FORMUL 7 PHX 2(C14 H12 N2 O4) FORMUL 9 HOH *28(H2 O) HELIX 1 1 SER H 28 TYR H 32 5 5 HELIX 2 2 ASN H 52A GLY H 54 5 5 HELIX 3 3 SER J 28 TYR J 32 5 5 HELIX 4 4 ASN J 52A GLY J 54 5 5 HELIX 5 5 ARG J 83 SER J 87 5 5 HELIX 6 6 GLU L 79 LEU L 83 5 5 SHEET 1 HA 4 LYS H 3 SER H 7 0 SHEET 2 HA 4 LEU H 18 SER H 25 -1 O SER H 21 N SER H 7 SHEET 3 HA 4 ILE H 77 MET H 82 -1 O LEU H 78 N CYS H 22 SHEET 4 HA 4 THR H 68 ARG H 71 -1 O THR H 68 N GLN H 81 SHEET 1 HB 5 THR H 57 TYR H 59 0 SHEET 2 HB 5 GLU H 46 ILE H 51 -1 O PHE H 50 N ASP H 58 SHEET 3 HB 5 MET H 34 GLN H 39 -1 O MET H 34 N ILE H 51 SHEET 4 HB 5 THR H 89 ARG H 94 -1 O THR H 89 N GLN H 39 SHEET 5 HB 5 THR H 107 LEU H 108 -1 O THR H 107 N TYR H 90 SHEET 1 HC 5 THR H 57 TYR H 59 0 SHEET 2 HC 5 GLU H 46 ILE H 51 -1 O PHE H 50 N ASP H 58 SHEET 3 HC 5 MET H 34 GLN H 39 -1 O MET H 34 N ILE H 51 SHEET 4 HC 5 THR H 89 ARG H 94 -1 O THR H 89 N GLN H 39 SHEET 5 HC 5 TYR H 102 TRP H 103 -1 O TYR H 102 N ARG H 94 SHEET 1 JA 4 LYS J 3 SER J 7 0 SHEET 2 JA 4 ARG J 19 SER J 25 -1 O SER J 21 N SER J 7 SHEET 3 JA 4 ILE J 77 MET J 82 -1 O LEU J 78 N CYS J 22 SHEET 4 JA 4 PHE J 67 ASP J 72 -1 O THR J 68 N GLN J 81 SHEET 1 JB 5 GLY J 10 VAL J 12 0 SHEET 2 JB 5 THR J 107 VAL J 111 1 O LEU J 108 N GLY J 10 SHEET 3 JB 5 ALA J 88 ARG J 94 -1 O ALA J 88 N VAL J 109 SHEET 4 JB 5 MET J 34 GLN J 39 -1 O ALA J 35 N ALA J 93 SHEET 5 JB 5 GLU J 46 ILE J 51 -1 O GLU J 46 N ARG J 38 SHEET 1 JC 4 GLY J 10 VAL J 12 0 SHEET 2 JC 4 THR J 107 VAL J 111 1 O LEU J 108 N GLY J 10 SHEET 3 JC 4 ALA J 88 ARG J 94 -1 O ALA J 88 N VAL J 109 SHEET 4 JC 4 TYR J 102 TRP J 103 -1 O TYR J 102 N ARG J 94 SHEET 1 KA 4 MET K 4 THR K 7 0 SHEET 2 KA 4 ALA K 19 SER K 25 -1 O SER K 22 N THR K 7 SHEET 3 KA 4 ASP K 70 ILE K 75 -1 O PHE K 71 N CYS K 23 SHEET 4 KA 4 GLY K 66 SER K 67 -1 N SER K 67 O ASP K 70 SHEET 1 KB 6 SER K 10 PRO K 12 0 SHEET 2 KB 6 THR K 102 GLU K 105 1 O LYS K 103 N LEU K 11 SHEET 3 KB 6 GLY K 84 GLN K 90 -1 O GLY K 84 N LEU K 104 SHEET 4 KB 6 LEU K 33 GLN K 38 -1 O GLU K 34 N PHE K 89 SHEET 5 KB 6 LYS K 45 TYR K 49 -1 O LYS K 45 N LEU K 37 SHEET 6 KB 6 ASN K 53 ARG K 54 -1 O ASN K 53 N TYR K 49 SHEET 1 KC 4 SER K 10 PRO K 12 0 SHEET 2 KC 4 THR K 102 GLU K 105 1 O LYS K 103 N LEU K 11 SHEET 3 KC 4 GLY K 84 GLN K 90 -1 O GLY K 84 N LEU K 104 SHEET 4 KC 4 THR K 97 PHE K 98 -1 O THR K 97 N GLN K 90 SHEET 1 LA 4 MET L 4 THR L 7 0 SHEET 2 LA 4 ALA L 19 SER L 25 -1 O SER L 22 N THR L 7 SHEET 3 LA 4 ASP L 70 ILE L 75 -1 O PHE L 71 N CYS L 23 SHEET 4 LA 4 PHE L 62 SER L 67 -1 O SER L 63 N LYS L 74 SHEET 1 LB 8 ASN L 53 ARG L 54 0 SHEET 2 LB 8 LYS L 45 TYR L 49 -1 O TYR L 49 N ASN L 53 SHEET 3 LB 8 LEU L 33 GLN L 38 -1 O TRP L 35 N LEU L 47 SHEET 4 LB 8 VAL L 85 GLN L 90 -1 O VAL L 85 N GLN L 38 SHEET 5 LB 8 THR L 97 PHE L 98 -1 O THR L 97 N GLN L 90 SHEET 6 LB 8 VAL L 85 GLN L 90 -1 O GLN L 90 N THR L 97 SHEET 7 LB 8 THR L 102 LYS L 103 -1 O THR L 102 N TYR L 86 SHEET 8 LB 8 VAL L 85 GLN L 90 -1 O TYR L 86 N THR L 102 SSBOND 1 CYS H 22 CYS H 92 SSBOND 2 CYS J 22 CYS J 92 SSBOND 3 CYS K 23 CYS K 88 SSBOND 4 CYS L 23 CYS L 88 LINK NH2 ARG K 54 OAL PHX H1114 LINK NH2 ARG L 54 OAP PHX J1114 LINK NH2 ARG L 54 OAL PHX J1114 LINK NH2 ARG L 54 CAK PHX J1114 CISPEP 1 THR K 7 PRO K 8 0 0.00 CISPEP 2 VAL K 94 PRO K 95 0 0.00 CISPEP 3 THR L 7 PRO L 8 0 0.34 CISPEP 4 VAL L 94 PRO L 95 0 0.32 SITE 1 AC1 11 ASP H 31 TYR H 32 TYR H 33 ASN H 52A SITE 2 AC1 11 GLY H 95 ASP H 96 TYR H 97 GLY H 99 SITE 3 AC1 11 TRP H 100A ARG K 54 HOH H1008 SITE 1 AC2 9 ASP J 31 TYR J 32 TYR J 33 GLY J 95 SITE 2 AC2 9 SER J 96 TYR J 97 GLY J 99 ARG L 54 SITE 3 AC2 9 ASP L 60 CRYST1 140.940 75.660 52.850 90.00 111.33 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007095 0.000000 0.002771 0.00000 SCALE2 0.000000 0.013217 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020313 0.00000 MTRIX1 1 0.795990 -0.055560 0.602750 8.10398 1 MTRIX2 1 -0.051710 -0.998380 -0.023750 37.55256 1 MTRIX3 1 0.603100 -0.012270 -0.797570 -21.34938 1 MTRIX1 2 0.795990 -0.055560 0.602750 8.10398 MTRIX2 2 -0.051710 -0.998380 -0.023750 37.55256 MTRIX3 2 0.603100 -0.012270 -0.797570 -21.34938 MTRIX1 3 0.795990 -0.055560 0.602750 8.10398 MTRIX2 3 -0.051710 -0.998380 -0.023750 37.55256 MTRIX3 3 0.603100 -0.012270 -0.797570 -21.34938